1. Profile

SOTHEMA

Last Updated:
  • 950.00 MAD
  • 5.00
  • 0.53%
الشركة المغربية للعلاج
سوطيما
Symbol : SOT
ISIN : MA0000012502
52-Week Range : 881.00 - 1,075.00
Turnover Ratio : 0.02
Market : Casablanca Stock Exchange
Sector : Pharmaceuticals
Industry : Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :

Basic Information

  • Activity :
    Societe de Therapeutique Marocaine SA (known as: Sothema) is a public company, listed on Casablanca Stock Exchange since February 2005. SOTHEMA operates within the pharmaceuticals, biotechnology & life...
  • Industry Group :
    pharmaceuticals Research and Biotechnology
  • Sub-Industry :
  • ISIN :
    MA0000012502
  • Contact Person :
    Adnane Hilal
  • Established On:
    26-Jan-1976
  • Stock Listing On :
    21-Feb-2005
  • No of Employees :
    --
  • Outstanding Shares :
    7,200,000
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :

Indices Membership

Action Date Index Provider
Join 2013 MASI Casablanca Stock Exchange
Join 2005 MASI Pharmaceutical Industry Casablanca Stock Exchange
Societe de Therapeutique Marocaine SA
Zone industriel, Bouskoura- Bouskoura 27182
T : +212 5 22437040
F : +212 5 22437045
www.sothema.com
sothema@sothema.ma

Management

Title Name As Of
Chairman: Lamia Tazi 2019
Board Member: El Ghaly Hassani 2011
Mohamed Berrada 2013
Salma Tazi 2018
Mohamed Sefrioui 2013
Amal Diouri 2014
Mohamed Berrada 2013
Bahia Berrada 2020
Ali Tazi 2018
amine Benhalima 2020

Reports

Date Title File
2024 Sothema Quarterly Financials Report Q2 2024
2024 Sothema Annual Financials Report 2023
2023 Sothema Quarterly Financials Report Q2 2023
2023 Sothema Annual Financials Report 2022
2022 Sothema Quarterly Financials Report Q2 2022
2022 Sothema Annual Financials Report 2021
2021 Sothema Quarterly Financials Report Q2 2021
2021 Sothema CP Relating to the Capital Increase by Incorporation of Reserves
2020 Sothema Quarterly Financials Report Q2 2020
2020 Sothema Annual Financials Report 2019
2019 Sothema Quarterly Financials Report Q2 2019
Check our coverage for
Check The List